Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 4, 2010, Pages 575-581

  Zhou, Shanghui ^a   Qu, Xingzhou ^a   Yu, Zhiwei ^a   Zhong, Laiping ^a   Ruan, Min ^a   Ma, Chunyue ^a   Wang, Mingyi ^a   Zhang, Chenping ^a   Jian, Xinchun ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BIRC5 PROTEIN, HUMAN; CYSTEINE PROTEINASE INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER STAGING; CELL TRANSFORMATION; CLASSIFICATION; COMPARATIVE STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH DISEASE; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; ULTRASTRUCTURE; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE PROTEINASE INHIBITORS; CYTOPLASM; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; ORAL SUBMUCOUS FIBROSIS; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77949614359     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.10.054     Document Type: Article

References (37)

1. Scully C. Oral precancer: preventive and medical approaches to management. Eur J Cancer B Oral Oncol 31B (1995) 16-26
2. Lippman S.M., Sudbo J., and Hong W.K. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23 (2005) 346-356
3. Schepman K., der Meij E., Smeele L., and der Waal I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 5 (1999) 206-209
4. Pindborg J.J., and Sirsat S.M. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 22 (1966) 764-779
5. Zhang X., and Reichart P.A. A review of betel quid chewing, oral cancer and precancer in Mainland China. Oral Oncol 43 (2007) 424-430
6. Pindborg J.J., Murti P.R., Bhonsle R.B., Gupta P.C., Daftary D.K., and Mehta F.S. Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 92 (1984) 224-229
7. Gupta P.C., Sinor P.N., Bhonsle R.B., Pawar V.S., and Mehta H.C. Oral submucous fibrosis in India: a new epidemic?. Natl Med J India 11 (1998) 113-116
8. Murti P.R., Bhonsle R.B., Pindborg J.J., Daftary D.K., Gupta P.C., and Mehta F.S. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 13 (1985) 340-341
9. Jian X.C., Shen Z.H., and Liu S.F. Oral submucous fibrosis-case reports. J Clin Stomatol 1 (1985) 12-13 Chinese
10. Gao Y.J., Ling T.Y., Yin X.M., Yao Z.G., and Tang J.Q. A retrospective study of malignant transformation of oral submucous fibrosis. J Clin Stomatol 21 (2005) 119-120
11. Li F., and Ling X. Survivin study: an update of "what is the next wave"?. J Cell Physiol 208 (2006) 476-486
12. Li F. Survivin study: what is the next wave?. J Cell Physiol 197 (2003) 8-29
13. Li F., and Brattain M.G. Role of the survivin gene in pathophysiology. Am J Pathol 169 (2006) 1-11
14. Wheatley S.P., and McNeish I.A. Survivin: a protein with dual roles in mitosis and apoptosis. Int Rev Cytol 247 (2005) 35-88
15. Sah N.K., Khan Z., Khan G.J., and Bisen P.S. Structural, functional and therapeutic biology of survivin. Cancer Lett 244 (2006) 164-171
16. Tanaka C., Uzawa K., Shibahara T., Yokoe H., Noma H., and Tanzawa H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82 (2003) 607-611
17. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 89 (2003) 2244-2248
18. Lo Muzio L., Pannone G., Leonardi R., Staibano S., Mignogna M.D., De Rosa G., et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82 (2003) 923-928
19. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours[M] (2005), IARC Press, Lyon
20. Sobin L.H. TNM classification of malignant tumour/UICC. 6th ed. (2002), Wiley-Liss, New York
21. Lu C.D., Altieri D.C., and Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58 (1998) 1808-1812
22. Ambrosini G., Adida C., and Altieri D.C. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
23. Duffy M.J., O'Donovan N., Brennan D.J., Gallagher W.M., and Ryan B.M. Survivin: a promising tumor biomarker. Cancer Lett 249 (2007) 49-60
24. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
25. O'Connor D.S., Grossman D., Plescia J., Li F., Zhang H., Villa A., et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 97 (2000) 13103-13107
26. Pennati M., Folini M., and Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 28 (2007) 1133-1139
27. Lo Muzio L., Farina A., Rubini C., Pezzetti F., Stabellini G., Laino G., et al. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett 225 (2005) 27-33
28. Rubini C., Zamparese R., Corsi F., Pedicillo M.C., Pannone G., Staibano S., et al. Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis. Histol Histopathol 22 (2007) 1241-1249
29. Kim M.J., Lim K.Y., Kim J.W., Nam I.W., Lee J.H., and Myoung H. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Lett 224 (2005) 253-261
30. Lin C.Y., Hung H.C., Kuo R.C., Chiang C.P., and Kuo M.Y. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol 41 (2005) 645-654
31. Jane C., Nerurkar A.V., Shirsat N.V., Deshpande R.B., Amrapurkar A.D., and Karjodkar F.R. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 35 (2006) 595-601
32. Pickering V., Jordan R.C., and Schmidt B.L. Elevated salivary endothelin levels in oral cancer patients-a pilot study. Oral Oncol 43 (2007) 37-41
33. Chen H.H., Yu C.H., Wang J.T., Liu B.Y., Wang Y.P., Sun A., et al. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Oral Oncol 43 (2007) 122-129
34. Li F., Yang J., Ramnath N., Javle M.M., and Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance?. Int J Cancer 114 (2005) 509-512
35. Engels K., Knauer S.K., Metzler D., Simf C., Struschka O., Bier C., et al. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 211 (2007) 532-540
36. Zhang M., Yang J., and Li F. Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment. J Exp Clin Cancer Res 25 (2006) 391-402
37. Jiang G., Li J., Zeng Z., and Xian L. Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma. Cancer Biol Ther 5 (2006) 435-440